Warrant Redemption

Archaea Energy Inc. (NYSE: LFG, LFG.WS) Announces Redemption of All Outstanding Public Warrants – BEGIN

HOUSTON–(BUSINESS WIRE)–Archaea Energy Inc. (“Archaea” or the “Company”) (NYSE: LFG) today announced that the Company will redeem all of its publicly held warrants (the “Public Warrants”) to purchase shares of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), that remain outstanding at 5:00 p.m., New York City […]

Archaea Energy Inc. (NYSE: LFG, LFG.WS) Announces Redemption of All Outstanding Public Warrants – BEGIN Read More »

SoFi Technologies, Inc. (NASDAQ: SOFI, SOFIW) Announces Redemption of All Outstanding Warrants – BEGIN

SAN FRANCISCO–(BUSINESS WIRE)– SoFi Technologies, Inc. (NASDAQ: SOFI), (“SoFi” or “the Company”), a leading digital personal finance company, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement,

SoFi Technologies, Inc. (NASDAQ: SOFI, SOFIW) Announces Redemption of All Outstanding Warrants – BEGIN Read More »

SoFi Technologies, Inc. Announces Redemption of All Outstanding Warrants

11/04/2021DOWNLOAD(OPENS IN NEW WINDOW) SAN FRANCISCO–(BUSINESS WIRE)– SoFi Technologies, Inc. (NASDAQ: SOFI), (“SoFi” or “the Company”), a leading digital personal finance company, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued

SoFi Technologies, Inc. Announces Redemption of All Outstanding Warrants Read More »

Janus International Group, Inc. (NYSE: JBI, JBI.WS) Completes Redemption of Warrants -END

TEMPLE, Ga.–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”) today announced that the Company will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated as of June 7, 2021

Janus International Group, Inc. (NYSE: JBI, JBI.WS) Completes Redemption of Warrants -END Read More »

Janus International Group, Inc. (NYSE: JBI, JBI.WS) Announces Redemption of Warrants -BEGIN

TEMPLE, Ga.–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”) today announced that the Company will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated as of June 7, 2021

Janus International Group, Inc. (NYSE: JBI, JBI.WS) Announces Redemption of Warrants -BEGIN Read More »

Janus International Group, Inc. (NYSE: JBI, JBI.WS) Announces Redemption of Warrants

TEMPLE, Ga.–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”) today announced that the Company will redeem all of its outstanding warrants (the “Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), that were issued under the Warrant Agreement, dated as of June 7, 2021

Janus International Group, Inc. (NYSE: JBI, JBI.WS) Announces Redemption of Warrants Read More »

Proterra (NASDAQ: PRTA, PTRAW) Announces Redemption of Public Warrants and Private Placement Warrants

BURLINGAME, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Proterra Inc (Nasdaq: PTRA) today announced that it will redeem all of its public warrants (the “Public Warrants”) and private placement warrants (the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”) to purchase shares of Proterra’s common stock (the “Common Stock”) that are governed

Proterra (NASDAQ: PRTA, PTRAW) Announces Redemption of Public Warrants and Private Placement Warrants Read More »

Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE, CEREW) -END

Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement,

Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE, CEREW) -END Read More »

Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE, CEREW)- BEGIN

Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement,

Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE, CEREW)- BEGIN Read More »

Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE, CEREW)

Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement,

Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE, CEREW) Read More »

error: Content is protected !!
Scroll to Top